Dr. Sprague is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Central St
Ste 800
Evanston, IL 60201Phone+1 847-570-2512Fax+1 847-570-1696
Education & Training
- University of ChicagoFellowship, Nephrology, 1986 - 1988
- Rush University Medical CenterResidency, Internal Medicine, 1983 - 1986
- Chicago Osteopathic Medical CenterInternship, Transitional Year, 1982 - 1983
- Michigan State University College of Osteopathic MedicineClass of 1982
Certifications & Licensure
- IL State License 1982 - 2026
- MI State License 1983 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Chicago Magazine: Top Doctors Castle Connolly, 2008, 2010, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease Start of enrollment: 2009 Oct 01
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
- A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsLong-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.Stuart M. Sprague, Markus Ketteler, Adrian Covic, Jürgen Floege, Viatcheslav Rakov
Hemodialysis International. International Symposium on Home Hemodialysis. 2018-10-01 - 28 citationsEffect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.Peter Rossing, Geoffrey A. Block, Melanie P. Chin, Angie Goldsberry, Hiddo J.L. Heerspink
Kidney International. 2019-10-01 - 1288 citationsDefinition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Sharon M. Moe, Tilman B. Drüeke, John Cunningham, Wayne K. Goodman, Kevin J. Martin
Kidney International. 2006-06-01
Professional Memberships
- Fellow
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: